Trump’s Options to Cap Drug Prices Wane After Rebate Retreat

(Bloomberg) -- The Trump administration’s options for lowering high prescription-drug costs are narrowing after the White House decided to abandon a proposal that would have saddled seniors with hi...

Bloomberg Quint

Add BloombergQuint App to Home screen.